Singapore, Oct. 13 -- Nanyang Technological University (NTU), Singapore and global biopharmaceutical company Boehringer Ingelheim will be investigating new approaches to treating obesity, following a new research collaboration agreement between both organisations. Under the collaboration, researchers from both partners will undertake two projects exploring different biological mechanisms that could potentially be targeted to develop new anti-obesity therapies.Obesity is a complex chronic disease involving multiple biological systems, affecting about one in eight people worldwide and a similar, rising share of adults in Singapore. It increases the risk of type 2 diabetes, cardiovascular disease and some cancers, and keeping weight off rema...